What follow-up laboratory tests are recommended after radical prostatectomy for prostate cancer?

Follow-up Laboratory Tests After Radical Prostatectomy for Prostate Cancer

After radical prostatectomy, measure serum PSA at 6-8 weeks post-surgery, then every 3-6 months for the first 3 years, every 6 months until year 5, and annually thereafter. 12

PSA Monitoring Schedule

The cornerstone of post-prostatectomy surveillance is serial PSA testing, with the following evidence-based intervals:

First Year Post-Surgery

• Initial PSA: 6-8 weeks after surgery (allows adequate washout period given PSA half-life) 1
• Frequency: Every 3-6 months 32
• More frequent testing (every 3 months) is appropriate for high-risk patients 2

Years 2-3

• Every 6 months 32

Years 4-5

• Every 6 months 2

Beyond 5 Years

• Annually 32

Defining Biochemical Recurrence

Biochemical recurrence is defined as PSA ≥0.2 ng/mL confirmed on a subsequent test 1. This is the AUA standard definition. Key points:

• Any detectable PSA should be repeated for confirmation to eliminate laboratory error 4
• A cutpoint between 0.2-0.4 ng/mL is most accurate for predicting clinical failure 4
• Lower values (0.2 ng/mL) increase sensitivity; higher values (0.4 ng/mL) improve specificity 4
• PSA should become undetectable within several weeks of surgery if all prostate tissue is removed 1

Digital Rectal Examination (DRE)

DRE is optional and not recommended as routine if PSA remains undetectable 33. However:

• Annual DRE may be appropriate to monitor for rare local recurrence without PSA elevation 22
• DRE can be omitted if PSA levels remain undetectable 2

Other Laboratory Tests

Routine imaging studies (bone scans, CT, MRI) are NOT recommended in asymptomatic patients with low PSA values 5:

• Bone scans have very low yield until PSA exceeds 30-40 ng/mL 5
• Probability of positive bone scan is <5% even with PSA 40-45 ng/mL 5
• Imaging should only be pursued when PSA indicates biochemical recurrence and results would change management

Risk-Stratified Approach

Recent evidence supports tailoring follow-up intensity to recurrence risk 6:

• Low-risk patients (favorable pathology, negative margins): Can have reduced frequency testing (4 consultations over 5 years)
• Intermediate-risk patients: Standard schedule (8 consultations over 5 years)
• High-risk patients (positive margins, extracapsular extension, seminal vesicle invasion): More intensive monitoring (10 consultations over 5 years, consider every 3 months initially)

Critical Pitfalls to Avoid

1. Testing PSA too early: Wait at least 6 weeks post-surgery to allow adequate washout 1

2. Single elevated PSA triggering intervention: Always confirm with repeat testing before initiating salvage therapy 41

3. Ordering routine imaging with low PSA: Bone scans and cross-sectional imaging have extremely low yield when PSA <10 ng/mL and should not be routine 5

4. Ignoring PSA persistence: Patients whose PSA never becomes undetectable represent a distinct high-risk population requiring closer monitoring 7

5. Uniform follow-up regardless of risk: Pathologic features (stage, grade, margins) should guide intensity of surveillance 6

The evidence consistently shows marked variation among international guidelines 33, but the most recent high-quality guidelines converge on the schedule outlined above, with PSA testing as the primary surveillance tool and selective use of other modalities only when clinically indicated.